Voyager Therapeutics, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

VYGR

organization

Jurisdiction: US-DELegal Form: XTIQ

ACTIVE

LEI: 54930082S4XVR0ZWCC74SIC: 2836

Also known as: Voyager Therapeutics, Inc.

SEC Insider

$125.3M

364 transactions

Summary

Voyager Therapeutics, Inc. (VYGR) is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $93.8MSales: $25.0M40 insiders

Date	Insider	Type	Value
2026-02-24	Sandrock Alfred(President and CEO)	Sell	$54K
2026-02-10	Sandrock Alfred(President and CEO)	Sell	$46K
2026-04-02	Sandrock Alfred(President and CEO)	Sell	$45K
2026-02-18	Sandrock Alfred(President and CEO)	Sell	$40K
2026-02-24	Swartz Robin(COO & CBO)	Sell	$24K
2026-02-24	Jorgensen Nathan D.(Chief Financial Officer)	Sell	$18K
2026-02-24	Carter Todd Alfred(Chief Scientific Officer)	Sell	$16K
2026-02-10	Carter Todd Alfred(Chief Scientific Officer)	Sell	$14K
2026-02-18	Swartz Robin(COO & CBO)	Sell	$13K
2026-02-18	Carter Todd Alfred(Chief Scientific Officer)	Sell	$11K
2026-06-09	PIERCE GLENN	A	$0
2026-06-09	Colon Grace	A	$0
2026-06-09	GERAGHTY JAMES A	A	$0
2026-06-09	Onyia Jude	A	$0
2026-06-09	Higgins Michael J	A	$0
2026-06-09	Vitale Nancy	A	$0
2026-06-09	Hyman Steven	A	$0
2026-06-09	MACKEY CATHERINE J	A	$0
2026-06-09	SCANGOS GEORGE A	A	$0
2026-04-01	Shiferman Gregory L.(SVP and General Counsel)	A	$0

Legal entity: GLEIF

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Voyager Therapeutics, Inc. — Contributions, Lobbying & Contracts | Poliscope